TY - JOUR
T1 - Causes of death in people living with HIV
T2 - Lessons from five health facilities in Eswatini
AU - Mafulu, Yves
AU - Khumalo, Sukoluhle
AU - Williams, Victor
AU - Ndabezitha, Sandile
AU - Nyandoro, Elisha
AU - Ndlovu, Nkosana
AU - Kay, Alexander
AU - Maseko, Khetsiwe
AU - Simelane, Hlobsile
AU - Gwebu, Siphesihle
AU - Musarapasi, Normusa
AU - Mafukidze, Arnold
AU - Bongomin, Pido
AU - Dube, Nduduzo
AU - Buzaalirwa, Lydia
AU - Dube, Nkululeko
AU - Haumba, Samson
N1 - Publisher Copyright:
© 2024. The Authors. Licensee: AOSIS.
PY - 2024
Y1 - 2024
N2 - Background: Eswatini has a high HIV prevalence in adults and, despite being one of the first countries to achieve the UNAIDS 95-95-95 targets, AIDS-related deaths are still high. Objectives: This study describes the causes of death among people living with HIV (PLHIV) receiving care at five clinics in Eswatini. Method: A cross-sectional review of sociodemographic, clinical and mortality data of deceased clients who received care from 01 January 2021 to 30 June 2022, was conducted. Data were extracted from the deceased clients’ clinical records, and descriptive and comparative analysis was performed. Results: Of 257 clients, 52.5% (n = 135) were male, and the median age was 47 years (interquartile range [IQR]: 38, 59). The leading causes of death were non-communicable diseases (NCDs) (n = 59, 23.0%), malignancies (n = 37, 14.4%), COVID-19 (n = 36, 14.0%), and advanced HIV disease (AHD) (n = 24, 9.3%). Clients who had been on antiretroviral therapy (ART) for 12–60 months (OR: 0.01; 95% confidence interval [CI]: 0.0006, 0.06) and > 60 months (OR: 0.006; 95% CI: 0.0003, 0.029) had lower odds of death from AHD compared to those on ART for < 12 months. Clients aged ≥ 40 years had higher odds of dying from COVID-19, while female clients (OR: 2.64; 95% CI: 1.29, 5.70) had higher odds of death from malignancy. Conclusion: Most clients who died were aged 40 years and above and died from NCD-related causes, indicating a need to integrate prevention, screening, and treatment of NCDs into HIV services. Specific interventions targeting younger PLHIV will limit their risk for AHD.
AB - Background: Eswatini has a high HIV prevalence in adults and, despite being one of the first countries to achieve the UNAIDS 95-95-95 targets, AIDS-related deaths are still high. Objectives: This study describes the causes of death among people living with HIV (PLHIV) receiving care at five clinics in Eswatini. Method: A cross-sectional review of sociodemographic, clinical and mortality data of deceased clients who received care from 01 January 2021 to 30 June 2022, was conducted. Data were extracted from the deceased clients’ clinical records, and descriptive and comparative analysis was performed. Results: Of 257 clients, 52.5% (n = 135) were male, and the median age was 47 years (interquartile range [IQR]: 38, 59). The leading causes of death were non-communicable diseases (NCDs) (n = 59, 23.0%), malignancies (n = 37, 14.4%), COVID-19 (n = 36, 14.0%), and advanced HIV disease (AHD) (n = 24, 9.3%). Clients who had been on antiretroviral therapy (ART) for 12–60 months (OR: 0.01; 95% confidence interval [CI]: 0.0006, 0.06) and > 60 months (OR: 0.006; 95% CI: 0.0003, 0.029) had lower odds of death from AHD compared to those on ART for < 12 months. Clients aged ≥ 40 years had higher odds of dying from COVID-19, while female clients (OR: 2.64; 95% CI: 1.29, 5.70) had higher odds of death from malignancy. Conclusion: Most clients who died were aged 40 years and above and died from NCD-related causes, indicating a need to integrate prevention, screening, and treatment of NCDs into HIV services. Specific interventions targeting younger PLHIV will limit their risk for AHD.
KW - advanced HIV disease
KW - antiretroviral therapy
KW - cervical cancer
KW - COVID-19
KW - Eswatini
KW - HIV
KW - malignancies
KW - non-communicable disease
KW - people living with HIV
KW - tuberculosis
UR - http://www.scopus.com/inward/record.url?scp=85212342673&partnerID=8YFLogxK
U2 - 10.4102/sajhivmed.v25i1.1614
DO - 10.4102/sajhivmed.v25i1.1614
M3 - Article
AN - SCOPUS:85212342673
SN - 1608-9693
VL - 25
JO - Southern African Journal of HIV Medicine
JF - Southern African Journal of HIV Medicine
IS - 1
M1 - a1614
ER -